Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2023 Jan 7;224:104827. doi: 10.1016/j.biosystems.2023.104827

Decoding the double trouble: A mathematical modelling of co-infection dynamics of SARS-CoV-2 and influenza-like illness

Suman Bhowmick b,, Igor M Sokolov b,c, Hartmut HK Lentz a
PMCID: PMC9825135  PMID: 36626949

Abstract

After the detection of coronavirus disease 2019 (Covid-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, Hubei Province, China in late December, the cases of Covid-19 have spiralled out around the globe. Due to the clinical similarity of Covid-19 with other flulike syndromes, patients are assayed for other pathogens of influenza like illness. There have been reported cases of co-infection amongst patients with Covid-19. Bacteria for example Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae, Mycoplasma pneumoniae, Chlamydia pneumonia, Legionella pneumophila etc and viruses such as influenza, coronavirus, rhinovirus/enterovirus, parainfluenza, metapneumovirus, influenza B virus etc are identified as co-pathogens.

In our current effort, we develop and analysed a compartmental based Ordinary Differential Equation (ODE) type mathematical model to understand the co-infection dynamics of Covid-19 and other influenza type illness. In this work we have incorporated the saturated treatment rate to take account of the impact of limited treatment resources to control the possible Covid-19 cases.

As results, we formulate the basic reproduction number of the model system. Finally, we have performed numerical simulations of the co-infection model to examine the solutions in different zones of parameter space.

Keywords: Covid-19, Co-infection, ODE, Sensitivity analysis, Invasion reproductive number

1. Introduction

Coronavirus belongs to a group of enveloped virus with a single-stranded RNA and viral particles bear a resemblance to a crown from which the name originates. It belongs to the order of Nidovirales, family of Coronaviridae, and subfamily of Orthocoronavirinae (Carlos et al., 2020). It can infect the mammals, including humans, giving rise to mild infectious disorders, sporadically causing to severe outbreaks clusters, such as those brought about by the “Severe Acute Respiratory Syndrome” (SARS) virus in 2003 in mainland China (Gralinski and Menachery, 2020).

After the first reported case of new coronavirus disease outbreak in Wuhan, Hubei province, People’s Republic of China, the virus has progressively disseminated to different countries in the world (Lai et al., 2020). WHO declared it as a global pandemic on 11 March, 2020 (Cucinotta and Vanelli, 2020). This disease can spread from person-to-person through the breathing in of respiratory droplets from an infected person or having the direct contact with contaminated surfaces (Bai et al., 2020).

The ending season and the culminating severity of the current Covid-19 pandemic wave are still unknown and unsettled issue. Meanwhile, the influenza season has collided with the current pandemic that could pave the way for more challenges. This possesses a larger threat to public health domain. It is still uncertain how the seasonal influenza-like illness (ILI) will have an impact on the long-term effects on the course of Covid-19 pandemic. Both viruses share similarities in transmission characteristics and alike clinical symptoms. ILI and Covid-19 have been reported to cause respiratory infection. The interplay between ILI and Covid-19 have been a major concern (Konala et al., 2020). An emerging study from England has shown that fatality amongst the people infected with both ILI and Covid-19 are twice as that of someone infected with the new coronavirus only (Iacobucci, 2020). An investigation conducted by the Public Health England (PHE) has shown that people infected with the two viruses were having higher risk of severe illness during the period from January to April 2020. According to the same analysis, most cases of co-infection occurred in older people, and the mortality rate was high. Reports from the USA point out that co-infection between Covid-19 and other respiratory pathogens are notably more common compared to the initial data what suggest such an interplay is rare found in China (Kim et al., 2020, Chen et al., 2020). The authors in Hazra et al. (2020) report the co-infections between Covid-19 and other respiratory pathogens at a large urban medical centre in Chicago, Illinois. A study (Burrel et al., 2021) reveals that 7% of SARS-CoV-2-positive patients share the burden of co-infection with other respiratory viruses. According to that study the detection of other respiratory viruses in patients during this pandemic assumes the Covid-19 co-infection. The authors in Alosaimi et al. (2021) note that high prevalence of influenza-Covid-19 co-infection in their study. In Singh et al. (2020), the authors describe the cases of influenza and Covid-19 co-infection. During the last winter and autumn, the co-circulation of influenza-Covid-19 has taken a toll on the health of the patients and taxing the intensive care capacity (Covin and Rutherford, 2020, Belongia and Osterholm, 2020). The authors in the study (Bai et al., 2021) mention that co-infection with influenza A virus enhances the infectivity of Covid-19. This is undoubtedly, a significant threat that co-infection of ILI and Covid-19 possess.

Proper and appropriate nursing and treatment processes can significantly reduce the outcome of epidemics in society. In traditional epidemiological modelling assumption, the treatment rate is hypothesised to be constant or correspond to the number of infected people and the recovery rate reckons on the available medical resources such as test kits, ventilators, nursing facilities, efficiency of treatment etc. In the course of the ongoing pandemic, we have noticed how this pandemic has stretched the healthcare systems of different countries around the globe while registering high mortality (Cavallo et al., 2020, Mirmirani and Spivack, 1993, Gai and Tobe, 2020). In the classical epidemiological models, it is very common to use the treatment function as T(I)=ξI,I0, where ξ is positive but in the situation of sudden epidemic or pandemic when the infected population is very large then it is not always possible to provide such a type of treatment which is proportional to the infected number of individuals and I is the number of infected people. To circumvent the crux, the authors in Wang and Ruan (2004) have introduced a constant treatment rate of the form and demonstrated different bifurcations. But to sustain such a constant treatment rate might be plausible when there are a small number of infected individuals as the medical resources are limited (Griffin, 2019). Following this, the authors in Zhou and Fan, 2012, Zhonghua and Yaohong, 2010, Zhang and Liu, 2008 have modified the treatment rate by taking account of Holling type II functional response as given below: T(I)=ηI1+ζI and have explored the model dynamics to understand the importance of limited medical resources and facilities in the dissemination of infectious diseases. It is important to note that this function is clearly an increasing function of I and is bounded above by the least upper bound η/ζ. This functional form of saturated treatment can provide a better rationale for different disease outbreaks such as SARS, Dengue etc (Zhou and Fan, 2012) in a new region because we know from our ongoing Covid-19 pandemic experience that in the beginning of an outbreak there is a lack of effective treatment due to either negligence or lack of knowledge about the disease. But afterwards the treatment is being increased with the gain of knowledge about the disease as well scaling up medical facilities (Barlow et al., 2021). Eventually, the treatment rate is outstretched to its maximum given the boundedness of medical resources of any country (Armocida et al., 2020). Here, η represents cure rate and ζ denotes the extent of the effect of the infected individuals being delayed for treatment (Zhonghua and Yaohong, 2010).

Epidemiological models are quite beneficial to examine the co-infection dynamics and to estimate the treatment facilities. There are several studies concentrating on the coexistence of two infectious agents in the susceptible hosts (Blyuss and Kyrychko, 2005, Mallela et al., 2016, Asaduzzaman et al., 2015, Tilahun, 2019). The authors in Arefin et al. (2020) have proposed a mean-filed based mathematical model that includes the simultaneous spreading of two strains of an ILI and the acceptance of vaccination which is based on evolutionary game theory in an infinite and well-mixed population. Recent studies compiled in Tanimoto (2021), have demonstrated how do the behavioural strategies can potentially minimise the individual risk as well as introduced the idea of universal dilemma strength. In Gao et al. (2016), the authors have proved a sufficient condition for coexistence of two infectious diseases. In the same vein, the authors in Tang et al. (2016)have proposed a new mathematical model Zika-dengue model while describing coupled dynamics of Zika-dengue. The authors in Merler et al. (2008) have asserted that pandemic outbreaks can possibly be controlled by co-infection with other acute respiratory infections that enhances the transmissibility of influenza virus. These suggest that co-infection can potentially change the course of current ongoing pandemic and induce multiple waves (Cacciapaglia et al., 2021, Fisayo and Tsukagoshi, 2021).

The basic reproduction number (R0) is a critical metric in epidemiology and it is used to determine whether a disease will persist in a population or not (Diekmann et al., 2010). Although it is a very useful threshold, it comes with some restrictions too. Many diseases are endemic to certain regions around the globe and henceforth, giving rise to the cases of co-infection in the communities. Therefore, it becomes necessary to study invasion reproductive numbers (IRNs) (Olawoyin and Kribs, 2019, Nuño et al., 2007, Britnee Crawford, 2009). It is defined as the number of secondary infections produced by an infected individual in a population where one or more other pathogens are endemic. This critical threshold has similar behaviour as of R0 i.e. if the IRN of an infectious agent is larger than 1, then the pathogen can transmit in a population infected with other diseases.

Since the first pneumonic case of Covid-19, reported in Wuhan City, Hubei Province, China, the world is witnessing the ravaging impact of this global pandemic. It is acknowledged that Indian Government has implemented timely control measures to mitigate the spread of this pandemic. However, in the current situation, medical resources are in a critical need and especially for an ethnically diverse country like India. This has in fact left an influence in the pattern of Covid-19 dissemination. The interplay of Covid-19 and other ILI, is of utmost importance as the cases of co-infection induces a higher cases of mortality. From the perspective of public health control, it is significant to quantify and analyse the burden of co-infection on the medical resources and consequently help to curb the cases of Covid-19. To address this major issue, we have proposed a deterministic dynamic model featuring the co-infection in a saturated medical facility. The primary goal of this current endeavour is to investigate the impact of co-infection in the dynamics of Covid-19. Additionally, we derive the analytical expression of IRN to understand the influence of ILI on the potential spread of Covid-19. We also perform the sensitivity analysis to figure out the essential parameters while taking account of limited medical resources in the modelling framework.

2. Model formulation and description

The host population is N and we divide the population into the following classes according to their health status: susceptible (SH), infected with Covid-19 only (IC), infected with ILI only (IF), co-infected (infected with Covid-19 and ILI simultaneously) (RCF), recovered from Covid-19 (RC), recovered from ILI (IF) and recovered from co-infection (RCF). In our model λH represents the constant recruitment rate, μH is the natural death rate, α and β denote the effective transmission probability rates with which susceptible individuals become infected with Covid-19 and ILI, respectively. We also take account of the transmission probabilities to be infected only with Covid-19, ILI or both diseases after having the contact with a co-infected individuals as: α(1β), (1α)β and αβ. We also include the disease induced death rates into our model. δC, δF and δCF represent the death rates for the Covid-19, ILI and co-infected individuals, respectively. Natural recovery rates for the Covid-19, ILI and co-infected individuals are denoted as γC, γF and γCF. We further consider a saturated treatment function rate as h(IJ)=ηIJ1+ζIJ, where J=C,F and CF respectively. We have not taken account of reinfection and exposed state and henceforth it is of SIR type model. To construct the ODE based co-infection model, we have followed Blyuss and Kyrychko (2005)Gao et al. (2016). We present the schematic diagram of the model (1) in the Fig. 1.

Fig. 1.

Fig. 1

Flowchart of a SARS-CoV-2 and influenza-like illness co-infection model. SH, IC, IF and ICF represent the fractions of the susceptible population, infected with Covid-19, Influenza-like illness and infected with both infectious agents, respectively. Details about the model parameters are mentioned in the Table 1.

The model equations are following:

dSHdt=λHμHSH[α(1β)+β(1α)+αβ]SHICFαSHICβSHIF (1)
dICdt=αSHIC+α(1β)SHICF(μH+δC+γC)ICβ(IF+ICF)ICh(IC)
dRCdt=γCIC+h(IC)μHRC
dIFdt=βSHIF+β(1α)SHICF(μH+δF+γF)IFα(IC+ICF)IFh(IF)
dRFdt=γFIF+h(IF)μHRF
dICFdt=αβSHICF+(α+β)IFIC+(αIF+βIC)ICF(δCF+γCF+μH)ICFh(ICF)
dRCFdt=γCFICF+h(ICF)μHRCF

In this paper, we further explore the SIR epidemic model with saturated treatment function as h(IJ)=ηIJ1+ζIJ, where J=C,F and CF respectively.

Table 1.

Parameters used in the model (1).

Parameter Description Value or range References
πH Recruitment rate. Varies over states Sardar et al. (2020)
μH Natural mortality rate Varies over states Sardar et al. (2020)
γC Recovery rate of Covid-19 Varies over states Sardar et al. (2020)
δC Average case fatality rate of Covid-19 Varies over states Sardar et al. (2020)
α Covid-19 transmission probability 0.09,0.89 Mahajan et al. (2020)
γF Recovery rate of ILI 0.07140.1998 Blyuss et al. (2018)
δF Average case fatality rate of ILI 0.01,0.021 Blyuss et al. (2018)
β ILI transmission probability 0.01,0.78 Kharis and Amidi (2018)
γCF Recovery rate of co-infection 0.033,0.1428 Assumed
δCF Average case fatality rate of co-infection 0.0189,0.0332 Nadim and Chattopadhyay (2020)
η Cure rate 0.2,0.95 Sezer et al. (2017)
ζ Extent of saturation 0.008,0.25 Sezer et al. (2017)

3. Qualitative analysis

3.1. Infectious model with Covid-19 only

In this subsection, analytical findings are made taking into consideration SARS Covid-19 only. The model equations are following:

dSHdt=λHμHSHαSHIC (2)
dICdt=αSHICμHICδCICγCICh(IC)
dRCdt=γCIC+h(IC)μHRC

3.1.1. Invariant region

Total population is NC=SH+IC+RC. Differentiating w.r.t time t and substituting the required expressions, we get:

dNCdtλHμHNC. (3)

After solving Eq. (3) provides the invariant region as,

Ψ=(SH,IC,RC)R3:0NCλHμH

Hence, the solution set is bounded in Ψ.

3.1.2. Positivity of solution

Utilising the first equation of system (2) and after rewriting it as,

dSHdtSH(μHαIC)..

On evaluating, it yields,

SHSH(0)exp(μH+αIC)dt.

Similarly, the result follows for other equations proving the positivity of solutions.

3.1.3. Disease free equilibrium (DFE) and basic reproduction number R0C

On substituting IC=0, system (2) possesses the disease free equilibrium point (λHμH,0,0). Thereby, RC is evaluated using the next generation matrix method approach as,

R0C=αλHμH(μH+δC+γC+η)..

3.1.4. Local stability of DFE

Theorem 1

The DFE of system (2) is locally asymptotically stable if R0C<1 and unstable if R0C>1 .

Proof

The variational matrix governing the system at DFE is;

JC=μHαλHμH00αλHμHμHδCγCη00γC+ημH.

The eigenvalues are given by λ1=μH, λ2=μH with λ3=αλHμHμHδCγCη=R0C1 having real negative part if and only if R0C<1 which proves the theorem.

3.1.5. Global stability of DFE

Theorem 2

The DFE of system (2) is globally asymptotically stable if R0C<1 .

Proof

Define Lyapunov function as;

L=a.IC,
dLdt=aαSHICa(μH+δC+γC+h(IC))dLdt=(αSHμH+δC+γC+η1)IC,
dLdt<0 if R0C1.

Hence, the result follows.

3.1.6. Endemic equilibrium analysis

The endemic equilibrium is EP=(SH,IC,RC) where, SH=λHμH+αIC, RC=ηIC1+ζIC and IC is a positive root of the quadratic equation, IC2+b1IC+b2=0, where b1=μHζ+α+ηαλHζαμH+δC+γC and b2=(1R0C)μH(μH+δC+γC+η)α(μH+δC+γC).

Theorem 3

The endemic equilibrium is globally stable in region ϕ if,

I. μH(μH+δC+γCη1+ζIC)>α2(SIC)24 ,

II. μH[μH(μH+δC+γCη1+ζIC)14(γC+ηη1+ζIC)2]>α(SHIC)2[αμH(SHIC)2]

Proof

Define V=12(SHSH)2+12(ICIC)2+12(RR)2. Differentiating with respect to time t, we get, dVdt=(SHSH)dSHdt+(ICIC)dICdt+(RR)dRdt,

On substituting the required expressions and simplifying, we get, (SHSH)2[μHαIC]+(ICIC)2[μH+αSHδCγCη1+ζIC+η1+ζIC]μH(RCRC)2+(ICIC)(RCRC)[γC+η1+ζICη1+ζI]+(SHSH)(ICIC)[α(SHIC)]

dVdt is negative definite in the region ϕ subject to the fulfilment of conditions I and II.

4. Co-infection model system

In this section we find the basic reproduction number, R0 of the entire model system as defined in (1) after following the Next Generation Matrix (NGM) method as described in Diekmann et al. (2010). R0 characterises the average number of new reported cases of an infection caused by one infected individual, in a completely susceptible population. Entries of NGM relate to the numbers of newly infected individuals in the various categories in consecutive generations.

To apply the NGM approach, we notice that the variables associated with Covid-19, ILI and Co-infected stages are (IC,IF,ICF) and SH as the susceptible compartments. Denoting YI=(IC,IF,ICF) and YS=SH, we can rewrite the associated system as the difference between the new-infection terms (inflow) and outflow terms then we have,

dYIdt=FCF(YS,YI)VCF(YS,YI) (4)
FCF=αSHIC+(α(1β)SHICF)(β(IF+ICF)IC)βSHIF+(β(1α)SHICF)(α(IC+ICF)IF)αβSHICF+(ICF(αIF+βIC))+((α+β)ICIF)
VCF=μHIC+δCIC+γCIC+ηIC/(1+ζIC)μHIF+δFIF+γFIF+ηIF/(1+ζIF)μHICF+δCFICF+γCFICF+ηICF/(1+ζICF)

So, after computing the Jacobians of FCF and VCF at the disease free equilibrium (DFE) point, i.e. FCF and VCF respectively, we have the NGM=FCFVCF1. The matrices for FCF and VCF are described in Box I.

Box I.

FCF=SHαβICF+IFICβICβSHαβ1IFαSHβαIC+ICFIFαSHβα1ICFβ+IFα+βICFα+ICα+βIFα+ICβ+SHαβ

and

VCF=δC+γC+μH+ηICζ+1ICηζICζ+12000δF+γF+μH+ηIFζ+1IFηζIFζ+12000δCF+γCF+μH+ηICFζ+1ICFηζICFζ+12
NGM=αλHμHδC+η+γC+μH0αλHβ1μHδCF+η+γCF+μH0βλHμHδF+η+γF+μHβλHα1μHδCF+η+γCF+μH00αβλHμHδCF+η+γCF+μH

According to van den Driessche and Watmough (2002), the basic reproduction number R0 is defined be the spectral radius of NGM at DFE. So,

R0=max{R0C,R0F,R0CF}, (5)

where R0C, R0F and R0CF are defined to be the basic reproduction numbers associated with Covid-19 only, Influenza like illness (ILI) and co-infected with Covid-19 and ILI. The expressions for R0F and R0CF are derived as :

R0F=βλHμH(μH+δF+γF+η) and R0CF=αβλHμH(μH+δCF+γCF+η).

5. Stability analysis

From the matrix given in Box II, the eigenvalues (λis) corresponding to the above matrix are given by; λ1=μH<0,λ2=αλHμHηγCμHδC,λ3=μH<0,λ4=βλHμHηγFμHδF,λ5=μH<0,λ6=αβλHμHηγCFμHδCF,λ7=μH<0. Therefore, the following are the requisites of stable DFE, αλHμHηγCμHδC<0R0C<1, βλHμHηγFμHδF<0R0F<1 and αβλHμHηγCFμHδCF<0R0CF<1. Hence, DFE is locally asymptotically stable iff R0=max{R0C,R0F,R0CF}<1 which proves the result.

Box II.

JCF=μHαλHμH0βλHμH0λHαβ1αβ+βα1μH00αλHμHηγCμHδC000αλHβ1μH00η+γCμH0000000βλHμHηγFμHδF0βλHα1μH0000η+γFμH0000000αβλHμHηγCFμHδCF000000η+γCFμH

5.0.7. Global stability of DFE

The defined system (1) can be written as,

dXdt=F(X,V), (6)
dVdt=G(X,V),G(X,0)=0,

where, X=(SH,RC,RF,RCF) which defines the total number of uninfected population compartments, V=(IC,IF,ICF) defines the total number of infected population compartments.

Let P=(λHμH,0,0,0,0,0,0) be the disease free equilibrium point of the system.

This disease free equilibrium point of the system is globally stable under the following two conditions:

  • 1.

    dXdt=F(X,0), X is globally asymptotically stable.

  • 2.

    G(X,V)=BVGˆ(X,V) for (X,V)Ω.

Where, B=D1G(X,0) is an M-matrix (having the off diagonal elements as nonnegative) and ω is the region with biological meaning.

Following from the results of Castillo-Chavez et al. (2002), we verify the following conditions:

F(X,0)=λHμHSH000
B=(μH+δC+γC)000(μH+δF+γF)0λHβ0(μH+δCF+γCF)+αβλH
G^(X,V)=(η1+ξICαSH)IC+(βICα(1β)SH)ICF+βIFIC(η1+ξIFβSH)IF+(αIFβ(1α)SH)ICF+αIFIC(η1+ξICFαβSH)ICF(α+β)IFIC(αIF+βIC)ICF

Therefore, G^(X,V)0 subject to the following requisites;

η1+ξM>αλH,
η1+ξM>βλH,
η1+ξM>αβλH,

along with the conditions as follows ; β>α1+α, α>β(1α)λH, λH>α+ββM and λH>αM+βMαβ where, M, M and M are the upper bounds of IC, IF and ICF respectively. Hence, the main result follows from Castillo-Chavez et al. (2002) which is stated below.

Theorem 4

The disease free equilibrium point given by(λHμH,0,0,0,0,0,0), is globally asymptotically stable for the defined system ifR0<1and conditions in Section 5.0.7 hold true.

6. Invasion reproduction number R0Inv

It is to be noted that in (5), the terms represent the basic reproduction numbers corresponding to infection with either Covid-19 or ILI or with the both, respectively. If R0C>1, then Covid-19-19 can invade the DFE and if R0F>1, then ILI can invade the DFE. In general, if R0>1, then either Covid-19 or ILI or Co-infection can invade the mode system (1).

An invasion reproduction number R0Inv, can determine if the model system (1) is already infected with a single pathogen and in our case, it is ILI. We analyse what happens when Covid-19 invades the model system at the ILI equilibrium i.e. when R0F>1

The endemic equilibrium point for EF0=(SH,IF,RF) with ILI can be found as SH=λHμH+βIF, RF=ηIF1+ζIF and IF is a positive root of the quadratic equation, IF2+c1IF+c2=0, where c1=μHζ+β+ηβλHζβμH+δF+γF and c2=(1R0F)μH(μH+δF+γF+η)β(μH+δF+γF). For the calculation purpose we shall use the forms expressed as in EF0. We use the NGM approach to derive an invasion matrix NGMFInv associated with Covid-19 and ILI and thereafter we compute R0Inv. After following the notation in (4), we have the equation in Box III.

Box III.

dYIFInvdt=FFInv(YS,YIF)VFInv(YS,YIF) (7)
FFInv=SHαIFβ0SHαβ1IFαSHβIFαSHβα1IFα+β0IFα+SHαβ
VFInv=δC+η+γC+μH000δF+γF+μH+ηIFζ+1IFηζIFζ+12000δCF+η+γCF+μH
NGMFInv=IFβSHαδC+η+γC+μH0SHαβ1δCF+η+γCF+μHIFαδC+η+γC+μHSHβIFζ+12δF+η+γF+μH+IF2δFζ2+IF2γFζ2+IF2μHζ2+2IFδFζ+2IFγFζ+2IFμHζIFα+SHβα1δCF+η+γCF+μHIFα+βδC+η+γC+μH0IFα+SHαβδCF+η+γCF+μH

According to the authors in Allen et al. (2019), we can define the invasion reproduction number R0Inv as the spectral radius of the invasion matrix NGMFInv. Therefore, ρ(NGMFInv)=max{λ1,λ2,λ3}, where, λ1=SHβ(IFζ+1)2(δF+γF+μH)(1+IFζ)2+η, λ2,3=12a+g±(ag)2+4ce. The expressions for a,g,c and e are following: a=IFβSHαδC+η+γC+μH, g=IFα+SHαβδCF+η+γCF+μH, c=IFαδC+η+γC+μH and e=IFα+SHβα1δCF+η+γCF+μH.

The epidemiological metric R0Inv can be interpreted as the average number of new infected states that are being produced after an introduction of an average of one Covid-19 infected agent into the population infected with ILI.

7. Numerical simulation

7.1. Data fitting

We implement our model fitting for an epidemic period starting from when the Indian government formally announced the index cases of Covid-19 for the different states. We follow the authors in Okuonghae and Omame (2020) while performing the model fitting and the data has been downloaded from Anon (2020). Collected data contains the days under the lockdown period too and hence the impact of lockdown on the disease dynamics shall inherently capture the transmission rates in the different states of India. Using the available cumulative number of reported data, we actively seek to estimate the unknown model parameters and fit the infection trajectories of different states of India. Estimated parameters pertaining to the Covid-19 model are found to be heterogenous in the magnitude and potentially it shows the different infection paths. One thing is important to note that as at the time when the first Covid-19 case was declared in India, it would be extremely difficult to determine the exact number of individuals who were already infected. Hence, it might be an aspect that reflects through the heterogeneous distribution of the estimated parameters.

Fig. 2 shows that our model (2) is able to predict the temporal course of daily reported cases of Covid-19 at the national scale where the green dots are the reported cases and the red curves are fitting curves. It is readily observable from the fitted model that the growth is of exponential type and the influence of lockdown is clearly noticeable.

Fig. 2.

Fig. 2

The comparison between the reported Covid-19 cases in Gujarat, Maharashtra, Rajasthan, Uttar Pradesh, West Bengal, Delhi, Madhya Pradesh, Telengana, Haryana and the simulation of IC(t) from the model described in (2).

7.2. Real time R0 estimation

Precise assessment of the parameters that identify infectious transmission is crucial to optimise the different containment strategies. An epidemiological metric termed as the time-dependent reproduction Rt has acquired much needed appreciation due to the fact that it can estimate the expected number of secondary cases caused by each infected people in a temporal way (Nishiura and Chowell, 2009). The magnitude of Rt can provide us the information about the extremity of Covid-19 over different time points.

To derive the relationship between the daily Covid-19 incidence data and Rt, we have employed the EpiEstim package (Cori et al., 2021). We can observe from the Fig. 3 that the value of Rt ranges between 4.5 to 0.5. It is also noticeable that the temporal changes in the spread of Covid-19 in India, is highly heterogenous. India declared 24th of March, 2020, a nationwide lockdown for 21 days and its influence can be visible in the Fig. 3 as the value of Rt decreases. The magnitude of Rt differed across all the Indian states. Average Rt is found to be 1.98 with (95% CI 1.932.06) for the entirety of India during that period of interval and in the lockdown phase it is 2.77 (95% CI 2.652.92). We have observed the geographic differences in the magnitude of Rt across India. For example, Rt is observed to be greater than 2.5 for Maharashtra, Delhi, Telengana, whereas it is noticed to be lesser than 2.5 for UP, West Bengal, Rajasthan. Rt is found to be greater than 1 for most of the states during that period.

Fig. 3.

Fig. 3

Estimation of the time-dependent reproduction number (Rt) for an outbreak of Covid-19 in India. Estimates of the reproduction number throughout the outbreak (mean (solid-dotted line) and 95% credible interval (shaded area)) obtained from the incidence data shown in the Figure. To analyse the incidence data of Covid-19 in India, Rt is estimated on sliding windows of width 7 days.

7.3. Impact of transmission parameters

In this section we explore the influence of the transmission parameters (α and β) on the populations infected with Covid-19, ILI and co-infection cases (IC, IF and ICF) respectively. Here, we vary the values of α and β and observe the influence on the prevalence on the population.

For the demonstration purpose, we have chosen the initial conditions to be S(0)=995, IC(0)=5, IF(0)=2, ICF(0)=3, RC(0)=0, RF(0)=0 and RCF(0)=0. Parameter values are from the Table: (Number). Infection profiles of the model’s state variables are depicted in the Fig. 4 and Fig. 5 wherein it is visible the influence of transmission parameters (α and β) on the prevalence of Covid-19, ILI and co-infection. With the increase in the transmission rates, the sharp surge in infected population is noticeable and similarly with the lower magnitude of transmission rates, reduction in the infected population can give us the assurance of the measurements that are taken account to reduce the spread of Covid-19. It is interesting to the note that the dynamics of the model is not symmetric (see Fig. 4 and Fig. 5) to the changes performed in two different transmission parameters in spite of being symmetric in the model formulations. Fig. 5 shows us that higher transmissibility of Covid-19, can create a sudden upsurge of cases of Covid-19 and co-infected people. The interplay between the transmissibility of Covid-19 and ILI are very interesting to notice and it is being reflected in the dynamics of co-infected population. Even the low level of transmissibility of Covid-19, can be a hindrance for the eradication of co-infected cases whereas the influence of transmissibility of ILI is not equally importance. Therefore, it is of utmost importance to curb the value of α to protect the vulnerable population.

Fig. 4.

Fig. 4

Influence of β on the prevalence of Covid-19, ILI and co-infected population.

Fig. 5.

Fig. 5

Influence of α on the prevalence of Covid-19, ILI and co-infected population.

7.4. Impact of cure rate

In order to further analyse the model (1), we have chosen to observe the influence of cure rate on compartments that include Covid-19, ILI and co-infected population.

Dynamical behaviour of these compartments is interesting to note in the constant changes of η. From the Fig. 6, it is noticeable the changes in the cure rate can bring the cases of Covid-19, ILI down and consequently the cases of co-infection can also be brought down accordingly. Finally, as conceived, we can notice that with the increase in medical facilities like test kits, ventilators, nursing facilities, efficiency of treatment etc, the infected population (IC,IF,ICF) get recovered and a substantial reduction happens in the infected population. This observation can lead us to conclude that the better cure rate should be considered as an effective tool to reduce the infection amongst the susceptible population.

Fig. 6.

Fig. 6

The prevalence of Covid-19, ILI and co-infected population.

7.5. Time series

Investigations in the time series can allow us to get further inside in the consequences of the cases when the values of R0 is greater than one or less than one. The situation when R0<1, the disease-free equilibrium point is the only attractor for the system whereas when R0>1, then the endemic equilibrium point. Fig. 8 depicts the first case and the Fig. 7 depicts the latter. In this scenario, cases of Covid-19 can be reduced classically by simply increasing the value of η.

Fig. 8.

Fig. 8

The prevalence of Covid-19, ILI and co-infected population.

Fig. 7.

Fig. 7

The prevalence of Covid-19, ILI and co-infected population.

Additionally, in Fig. 9, we have shown the prevalence of the infected population with Covid-19, ILI and co-infection under two different situations.

Fig. 9.

Fig. 9

The prevalence of Covid-19, ILI and co-infected population.

It is clear from the Fig. 9 that if the value of R0 is greater than 1 then the prevalence of Covid-19, ILI and co-infected people are non-zero and the burden of people infected with Covid-19 and co-infected is higher compared to the people infected with ILI only and the same holds true when we let the value of R0 is to be less than 1.

7.6. Sensitivity analysis

Using sensitivity analysis, we can recognise which parameters are important providing the heterogeneity in the outcome of the basic reproduction number (R0). In our effort we focus primarily on global sensitivity analysis (GSA) which investigates the response of model output variables to the model parameters variation.

We have used Sobol’ method as we would like to gather the information about the response of R0 to a certain parameter while all interactions are taken into the account. Given the higher value of transmissibility of Covid-19 (Petersen et al., 2020), we choose to investigate R0C for the GSA in our simulation. Fig. 10(a) reveals that η has the highest ST index and it indicates that it contributes over 65% of R0C variance while accounting for interactions with other parameters, followed by α and λH. It is to be noted that particularly for the S1 index, it indicates each input’s individual contribution to variance. We use a more sophisticated visualisation to incorporate the second-order interactions between inputs estimated from the S2 values. In this case η has strong interactions with α and λH and then followed by the interaction between α and λH. Here, the size of the ST and S1 circles correlate with the normalised variable importances. Fig. 10 delivers a few important messages that shall be the matter of concern in the context of limited medical resources. Based on Sobol’ sensitivity index, Si, where i=1,2 three parameters are found to be primary contributors to the variance of transmissibility of Covid-19. It gives the information about the contributions of η, α and λH to the variance of basic reproduction number and the total effect index, ST includes both individual contributions and the interaction effects in consideration. It is evident that the influence of the effective transmission rate of Covid-19 and the treatment facility are very important to lower the value of R0 along with reducing the number of susceptible. Higher number of susceptible will take toll on the medical resources and henceforth, lack of treatment facility can facilitate higher transmission of Covid-19.

Fig. 10.

Fig. 10

Sobol’ indices.

8. Discussion and conclusion

Our work has revealed the co-infection dynamics of Covid-19 and ILI in the presence of non-linear treatment function in different states of India. After using our mathematical model with the available data at the initial phase of Covid-19 spread in India, we are able to fit the trajectories of the paths of Covid-19 infection over India and its exponential nature. By applying numerical simulations, we endeavour to understand the effect of saturated treatment in the course of co-infection. After finding the analytical expression of IRN, our current effort build on to the analytical tools which can be employed to understand the multiple-pathogens dynamical system.

We have carried out the sensitivity analysis of R0 of the co-infected system with respect to the model parameters. The outcome identifies three key parameters: the transmission rate of Covid-19: α, cure rate: η and the recruitment rate: πH, play a major role in the co-infection model in the backdrop of a limited medical resource facility. This suggests the vital roles of lockdown, quarantine, isolation and revamping the medical facilities as the first action shall reduce the number of susceptible people and the second one will make sure that limited medical facilities will not be overwhelmed in India.

The decrease in Rt can be attributed to the implementation of public health measures including social distancing, restrictions in mobility, contact tracing etc and a possible improvement in medical care facilities. Similar trend of reduction of Rt in India has been observed just like in China or in USA (Yuan et al., 2020, Singh et al., 2021). Earlier studies (Senapati et al., 2021, Shil et al., 2021, Achaiah et al., 2020) have addressed a varied magnitude of Rt from 1.03 to 4.18. These studies have utilised different data sources and the methods to find Rt. The time intervals considered in these studies are also different from our endeavour. So, these estimates cannot be compared readily.

One of the highlights of our work is the mathematical formulation of invasion reproduction number (Allen et al., 2019), which can mirror the situation whether Covid-19 can invade a susceptible population where another disease is already persistent (Iacobucci, 2020, Kim et al., 2020, Chen et al., 2020, Burrel et al., 2021, Hazra et al., 2020), with the aim to investigate the dynamics of co-infection. We would like to include that interplay between Covid-19 and ILI has a beneficial impact on the transmission of co-infection in a completely susceptible human population where ILI already exists. The mathematical expression of R0Inv is similar to that of derived in Allen et al. (2019).

It is to be noted that the model considered in this work is a rudimentary mathematical model through which we have focussed to understand the main dynamics of the spread of Covid-19 and ILI in a limited medical facility setting. Nevertheless, pathogens or the strains of diseases interacting and infecting the hosts may not only promote each other but can also compete or try to be independent. Therefore, it is interesting to investigate the obstructive effects of co-infection on the Covid-19 transmission after including the evolutionary nature of this virus (May and Nowak, 1995, Lawton, 2020). Furthermore, other factors such as seasonality, spatial heterogeneity will be equally important to address.

Our modelling foundation is not only tailored to carry out the co-transmission of Covid-19 and ILI, but can be employed to general epidemiological co-transmitting diseases in a limited medical resources. Predicting the spread of epidemics and developing an early forewarning system for the limited yet demanding healthcare and volume have been put at the foreground of epidemiological modelling. It can be achieved through working and planning in a close collaboration with the theoreticians and local authorities. As a consequence, it shall bring a unique opportunity to inculcate novel ideas to demanding healthcare options and planning.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Data availability

Data will be made available on request.

References

  1. Achaiah N.C., Subbarajasetty S.B., Shetty R.M. R(0) and r(e) of COVID-19: Can we predict when the pandemic outbreak will be contained? Indian J. Critical Care Med.: Peer-Reviewed, Off. Publication Indian Soc. Critical Care Med. 2020;24(11):1125–1127. doi: 10.5005/jp-journals-10071-23649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allen L.J.S., Bokil V.A., Cunniffe N.J., Hamelin F.M., Hilker F.M., Jeger M.J. Modelling vector transmission and epidemiology of co-infecting plant viruses. Viruses. 2019;11(12) doi: 10.3390/v11121153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Alosaimi B., Naeem A., Hamed M.E., Alkadi H.S., Alanazi T., Al Rehily S.S., Almutairi A.Z., Zafar A. Influenza co-infection associated with severity and mortality in COVID-19 patients. Virol. J. 2021;18(1):127. doi: 10.1186/s12985-021-01594-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Anon B. 2020. India COVID-19 tracker. [Google Scholar]
  5. Arefin M.R., Kabir K.M.A., Tanimoto J. A mean-field vaccination game scheme to analyze the effect of a single vaccination strategy on a two-strain epidemic spreading. J. Stat. Mech. Theory Exp. 2020;2020(3) [Google Scholar]
  6. Armocida B., Formenti B., Ussai S., Palestra F., Missoni E. The Italian health system and the COVID-19 challenge. Lancet Public Health. 2020;5(5) doi: 10.1016/S2468-2667(20)30074-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Asaduzzaman S.M., Ma J., van den Driessche P. The coexistence or replacement of two subtypes of influenza. Math. Biosci. 2015;270:1–9. doi: 10.1016/j.mbs.2015.09.006. [DOI] [PubMed] [Google Scholar]
  8. Bai Y., Yao L., Wei T., Tian F., Jin D.-Y., Chen L., Wang M. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323(14):1406–1407. doi: 10.1001/jama.2020.2565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bai L., Zhao Y., Dong J., Liang S., Guo M., Liu X., Wang X., Huang Z., Sun X., Zhang Z., Dong L., Liu Q., Zheng Y., Niu D., Xiang M., Song K., Ye J., Zheng W., Tang Z., Tang M., Zhou Y., Shen C., Dai M., Zhou L., Chen Y., Yan H., Lan K., Xu K. Coinfection with influenza a virus enhances SARS-CoV-2 infectivity. Cell Res. 2021;31(4):395–403. doi: 10.1038/s41422-021-00473-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Barlow P., van Schalkwyk M.C., McKee M., Labonté R., Stuckler D. COVID-19 and the collapse of global trade: building an effective public health response. Lancet Planet. Health. 2021;5(2):e102–e107. doi: 10.1016/S2542-5196(20)30291-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Belongia E.A., Osterholm M.T. COVID-19 and flu, a perfect storm. Science. 2020;368(6496):1163. doi: 10.1126/science.abd2220. [DOI] [PubMed] [Google Scholar]
  12. Blyuss K., Kanyiri C.W., Mark K., Luboobi L. Mathematical analysis of influenza a dynamics in the emergence of drug resistance. Comput. Math. Methods Med. 2018;2018 doi: 10.1155/2018/2434560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Blyuss K.B., Kyrychko Y.N. On a basic model of a two-disease epidemic. Appl. Math. Comput. 2005;160(1):177–187. [Google Scholar]
  14. Britnee Crawford C.M.K.-Z. The impact of vaccination and coinfection on HPV and cervical cancer. Discrete Contin. Dyn. Syst. B. 2009;12(2):279–304. [Google Scholar]
  15. Burrel S., Hausfater P., Dres M., Pourcher V., Luyt C.-E., Teyssou E., Soulié C., Calvez V., Marcelin A.-G., Boutolleau D. Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19. Int. J. Infect. Dis. 2021;102:10–13. doi: 10.1016/j.ijid.2020.10.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Cacciapaglia G., Cot C., Sannino F. Multiwave pandemic dynamics explained: how to tame the next wave of infectious diseases. Sci. Rep. 2021;11(1):6638. doi: 10.1038/s41598-021-85875-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Carlos W.G., Dela Cruz C.S., Cao B., Pasnick S., Jamil S. COVID-19 disease due to SARS-CoV-2 (novel coronavirus) Am. J. Respir. Crit. Care Med. 2020;201(4):P7–P8. doi: 10.1164/rccm.2014P7. [DOI] [PubMed] [Google Scholar]
  18. Castillo-Chavez C., Feng Z., Huang W. Springer-Verlag; New York: 2002. On the Computation of R0 and Its Role on Global Stability, Mathematical Approaches for Emerging and Reemerging Infectious Diseases: An Introduction. [Google Scholar]
  19. Cavallo J.J., Donoho D.A., Forman H.P. Hospital capacity and operations in the coronavirus disease 2019 (COVID-19) pandemic—Planning for the nth patient. JAMA Health Forum. 2020;1(3):e200345. doi: 10.1001/jamahealthforum.2020.0345. [DOI] [PubMed] [Google Scholar]
  20. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., Xia J., Yu T., Zhang X., Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi: 10.1016/S0140-6736(20)30211-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Cori A., Kamvar Z., Stockwin J., Jombart T., Dahlqwist E., FitzJohn R., Thompson R. 2021. EpiEstim v2.2-3: A tool to estimate time varying instantaneous reproduction number during epidemics. https://github.com/mrc-ide/EpiEstim. [Google Scholar]
  22. Covin S., Rutherford G.W. Coinfection, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and influenza: An evolving puzzle. Clin. Infect. Dis. 2020;72(12):e993–e994. doi: 10.1093/cid/ciaa1810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Cucinotta D., Vanelli M. WHO declares COVID-19 a pandemic. Acta Bio-Med.: Atenei Parmensis. 2020;91(1):157–160. doi: 10.23750/abm.v91i1.9397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Diekmann O., Heesterbeek J.A.P., Roberts M.G. The construction of next-generation matrices for compartmental epidemic models. J. R. Soc. Interface. 2010;7(47):873–885. doi: 10.1098/rsif.2009.0386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Fisayo T., Tsukagoshi S. Three waves of the COVID-19 pandemic. Postgrad. Med. J. 2021;97(1147):332. doi: 10.1136/postgradmedj-2020-138564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Gai R., Tobe M. Managing healthcare delivery system to fight the COVID-19 epidemic: experience in Japan. Glob. Health Res. Policy. 2020;5(1):23. doi: 10.1186/s41256-020-00149-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Gao D., Porco T.C., Ruan S. Coinfection dynamics of two diseases in a single host population. J. Math. Anal. Appl. 2016;442(1):171–188. doi: 10.1016/j.jmaa.2016.04.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Gralinski L.E., Menachery V.D. Return of the coronavirus: 2019-nCoV. Viruses. 2020;12(2) doi: 10.3390/v12020135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Griffin N. How the lack of government is affecting healthcare in Northern Ireland. BMJ. 2019;364 [Google Scholar]
  30. Hazra A., Collison M., Pisano J., Kumar M., Oehler C., Ridgway J.P. Coinfections with SARS-CoV-2 and other respiratory pathogens. Infect. Control Hosp. Epidemiol. 2020;41(10):1228–1229. doi: 10.1017/ice.2020.322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Iacobucci G. Covid-19: Risk of death more than doubled in people who also had flu, english data show. BMJ. 2020;370 doi: 10.1136/bmj.m3720. [DOI] [PubMed] [Google Scholar]
  32. Kharis M., Amidi M. Mathematical modeling of avian influenza epidemic with bird vaccination in constant population. J. Phys. Conf. Ser. 2018;983 [Google Scholar]
  33. Kim D., Quinn J., Pinsky B., Shah N.H., Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA. 2020;323(20):2085–2086. doi: 10.1001/jama.2020.6266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Konala V.M., Adapa S., Naramala S., Chenna A., Lamichhane S., Garlapati P.R., Balla M., Gayam V. A case series of patients coinfected with influenza and COVID-19. J. Investig. Med. High Impact Case Rep. 2020;8 doi: 10.1177/2324709620934674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Lai C.-C., Wang C.-Y., Hsueh P.-R. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? J. Microbiol., Immunol. Infect. 2020;53(4):505–512. doi: 10.1016/j.jmii.2020.05.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Lawton G. Could co-infection cause coronavirus to evolve? New Scientist (1971) 2020;247(3299):10–11. doi: 10.1016/S0262-4079(20)31559-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Mahajan A., Sivadas N.A., Solanki R. An epidemic model SIPHERD and its application for prediction of the spread of COVID-19 infection in India. Chaos Solitons Fractals. 2020;140 doi: 10.1016/j.chaos.2020.110156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Mallela A., Lenhart S., Vaidya N.K. HIV–TB co-infection treatment: Modeling and optimal control theory perspectives. J. Comput. Appl. Math. 2016;307:143–161. [Google Scholar]
  39. May R.M., Nowak M.A. Coinfection and the evolution of parasite virulence. Proc. R. Soc. B. 1995;261(1361):209–215. doi: 10.1098/rspb.1995.0138. [DOI] [PubMed] [Google Scholar]
  40. Merler S., Poletti P., Ajelli M., Caprile B., Manfredi P. Coinfection can trigger multiple pandemic waves. J. Theoret. Biol. 2008;254(2):499–507. doi: 10.1016/j.jtbi.2008.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Mirmirani S., Spivack R.N. Health care system collapse in the united states: Capitalist market failure! De Economist. 1993;141(3):419–431. [Google Scholar]
  42. Nadim S.S., Chattopadhyay J. Occurrence of backward bifurcation and prediction of disease transmission with imperfect lockdown: A case study on COVID-19. Chaos Solitons Fractals. 2020;140 doi: 10.1016/j.chaos.2020.110163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Nishiura H., Chowell G. In: The Effective Reproduction Number as a Prelude to Statistical Estimation of Time-Dependent Epidemic Trends. Chowell G., Hyman J.M., Bettencourt L.M.A., Castillo-Chavez C., editors. Springer Netherlands; Dordrecht: 2009. pp. 103–121. [Google Scholar]
  44. Nuño M., Chowell G., Wang X., Castillo-Chavez C. On the role of cross-immunity and vaccines on the survival of less fit flu-strains. Theor. Popul. Biol. 2007;71(1):20–29. doi: 10.1016/j.tpb.2006.07.002. [DOI] [PubMed] [Google Scholar]
  45. Okuonghae D., Omame A. Analysis of a mathematical model for COVID-19 population dynamics in Lagos, Nigeria. Chaos Solitons Fractals. 2020;139 doi: 10.1016/j.chaos.2020.110032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Olawoyin O., Kribs C. Invasion reproductive numbers for discrete-time models. Infect. Dis. Model. 2019;4:44–72. doi: 10.1016/j.idm.2019.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Petersen E., Koopmans M., Go U., Hamer D.H., Petrosillo N., Castelli F., Storgaard M., Al Khalili S., Simonsen L. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect. Dis. 2020;20(9):e238–e244. doi: 10.1016/S1473-3099(20)30484-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Sardar T., Nadim S.S., Rana S., Chattopadhyay J. Assessment of lockdown effect in some states and overall India: A predictive mathematical study on COVID-19 outbreak. Chaos Solitons Fractals. 2020;139 doi: 10.1016/j.chaos.2020.110078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Senapati A., Rana S., Das T., Chattopadhyay J. Impact of intervention on the spread of COVID-19 in India: A model based study. J. Theoret. Biol. 2021;523 doi: 10.1016/j.jtbi.2021.110711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Sezer M., Wangari I.M., Stone L. Analysis of a heroin epidemic model with saturated treatment function. J. Appl. Math. 2017;2017 [Google Scholar]
  51. Shil P., Atre N.M., Patil A.A., Tandale B.V., Abraham P. District-wise estimation of basic reproduction number (R0) for COVID-19 in India in the initial phase. Spatial Inf. Res. 2021 [Google Scholar]
  52. Singh B., Kaur P., Reid R.-J., Shamoon F., Bikkina M. COVID-19 and influenza co-infection: Report of three cases. Cureus. 2020;12(8):e9852. doi: 10.7759/cureus.9852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Singh B.B., Lowerison M., Lewinson R.T., Vallerand I.A., Deardon R., Gill J.P.S., Singh B., Barkema H.W. Public health interventions slowed but did not halt the spread of COVID-19 in India. Transbound. Emerg. Dis. 2021;68(4):2171–2187. doi: 10.1111/tbed.13868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Tang B., Xiao Y., Wu J. Implication of vaccination against dengue for Zika outbreak. Sci. Rep. 2016;6(1):35623. doi: 10.1038/srep35623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Tanimoto J. Springer; 2021. Sociophysics Approach to Epidemics. [Google Scholar]
  56. Tilahun G.T. Modeling co-dynamics of pneumonia and meningitis diseases. Adv. Difference Equ. 2019;2019(1):149. [Google Scholar]
  57. van den Driessche P., Watmough J. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math. Biosci. 2002;180(1):29–48. doi: 10.1016/s0025-5564(02)00108-6. [DOI] [PubMed] [Google Scholar]
  58. Wang W., Ruan S. Bifurcations in an epidemic model with constant removal rate of the infectives. J. Math. Anal. Appl. 2004;291(2):775–793. [Google Scholar]
  59. Yuan J., Li M., Lv G., Lu Z.K. Monitoring transmissibility and mortality of COVID-19 in europe. Int. J. Infect. Dis. 2020;95:311–315. doi: 10.1016/j.ijid.2020.03.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Zhang X., Liu X. Backward bifurcation of an epidemic model with saturated treatment function. J. Math. Anal. Appl. 2008;348(1):433–443. [Google Scholar]
  61. Zhonghua Z., Yaohong S. Qualitative analysis of a SIR epidemic model with saturated treatment rate. J. Appl. Math. Comput. 2010;34(1):177–194. [Google Scholar]
  62. Zhou L., Fan M. Dynamics of an SIR epidemic model with limited medical resources revisited. Nonlinear Anal. RWA. 2012;13(1):312–324. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data will be made available on request.


Articles from Bio Systems are provided here courtesy of Elsevier

RESOURCES